Hera BioLabs

Hera BioLabs is a privately held company located in Lexington, Kentucky. With 16 employees, the company generates $2 million in annual revenue. Hera BioLabs specializes in providing preclinical services and technologies, focusing on gene-editing and rat model creation. They offer the SRG™ rat, a highly immunocompromised rat model designed for oncology research, which has been validated for human tumor xenograft studies under the name OncoRat®. The company also possesses proprietary gene-editing technologies, including the piggyBac transposon and the Cas-CLOVER targeted nuclease system, used for cell-line modification and animal model creation. Hera BioLabs distinguishes itself through its innovative technologies and commitment to scientific rigor. Their offerings include gene-editing technologies, products, and the SRG rat, along with specialized services such as cell engineering and in vitro and in vivo oncology studies. Researchers in academia and industry can connect with Hera BioLabs via their website, herabiolabs.com.